Monopar Therapeutics Inc.MM

Monopar Therapeutics Inc.

28,44USDR
−2,49−8,05%
Ultimo aggiornamento il 8 mar, 00:21 GMT
USD
Nessun attivitàPre-mercato
Visualizza sui grafici
Indietro

EBIT su Monopar Therapeutics Inc..

Dati annuali
2016
2017
2018
2019
2020
2021
2022
2023
TTM
‪‪−12,00 M‬‬
‪‪−9,00 M‬‬
‪‪−6,00 M‬‬
‪‪−3,00 M‬‬
‪0,00‬
Periodo
Valore
Variazione
Variazione %
TTM
‪‪−7,00 M‬‬
+‪‪1,83 M‬‬
+‪20,75‬%
2023
‪‪−8,83 M‬‬
+‪‪1,70 M‬‬
+‪16,18‬%
2022
‪‪−10,54 M‬‬
‪‪−1,41 M‬‬
‪−15,44‬%
2021
‪‪−9,13 M‬‬
‪‪−2,62 M‬‬
‪−40,23‬%
2020
‪‪−6,51 M‬‬
‪‪−2,19 M‬‬
‪−50,54‬%
2019
‪‪−4,32 M‬‬
‪‪−992,61 K‬‬
‪−29,80‬%
2018
2017
2016
Dati trimestrali
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−3,20 M‬‬
‪‪−2,40 M‬‬
‪‪−1,60 M‬‬
‪‪−800,00 K‬‬
‪0,00‬
Periodo
Valore
Variazione
Variazione %
Q3 '24
‪‪−1,57 M‬‬
+‪‪213,88 K‬‬
+‪11,96‬%
Q2 '24
‪‪−1,79 M‬‬
‪‪−65,39 K‬‬
‪−3,79‬%
Q1 '24
‪‪−1,72 M‬‬
+‪‪188,60 K‬‬
+‪9,86‬%
Q4 '23
‪‪−1,91 M‬‬
+‪‪154,00 K‬‬
+‪7,45‬%
Q3 '23
‪‪−2,07 M‬‬
+‪‪262,22 K‬‬
+‪11,26‬%
Q2 '23
‪‪−2,33 M‬‬
+‪‪196,83 K‬‬
+‪7,80‬%
Q1 '23
‪‪−2,53 M‬‬
+‪‪383,96 K‬‬
+‪13,20‬%
Q4 '22
‪‪−2,91 M‬‬
‪‪−501,66 K‬‬
‪−20,84‬%
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20
Q2 '20
Q1 '20
Q4 '19
Q3 '19
Q2 '19
Q1 '19
Q4 '18
Q3 '18
Q2 '18
Q1 '18
Q4 '17
Q3 '17
Q2 '17
Q1 '17